South Korea

South Korea has supported patients from 28 different countries with little access to healthcare services.

Merck will use its Asia Pacific Bioprocessing Center for commercial manufacturing for its biotech and pharmaceutical clients.

Researchers developed a new paradigm in neurodegenerative diseases treatment.

High spending and an innovative R&D environment are expected to ensure attractiveness.

The timeline to set the cost is currently longer than that of the reimbursement decision.

The diagnostic imaging market is seen to grow at 5% between 2023 and 2030.

There has been a growing interest towards researching cancer screening in the country.

The “one-stop” centre provides testing and medical care services.

Advanced Sterilization Products gets recognised at the Healthcare Asia Medtech Awards 2022.

The launch of dual chamber leadless pacemakers can especially promote market growth.